Compare CELZ & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELZ | SURG |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5M | 6.4M |
| IPO Year | 2008 | 2019 |
| Metric | CELZ | SURG |
|---|---|---|
| Price | $0.96 | $0.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 599.3K | ★ 9.6M |
| Earning Date | 05-08-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.08 | 24.69 |
| EPS | N/A | ★ N/A |
| Revenue | $6,000.00 | ★ $56,962,920.00 |
| Revenue This Year | N/A | $136.77 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.62 | $0.15 |
| 52 Week High | $6.25 | $3.14 |
| Indicator | CELZ | SURG |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 37.70 |
| Support Level | $0.80 | $0.15 |
| Resistance Level | $1.97 | $0.94 |
| Average True Range (ATR) | 0.07 | 0.01 |
| MACD | -0.02 | 0.00 |
| Stochastic Oscillator | 4.01 | 32.94 |
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.